euro adhoc: Sanacorp Pharmaholding AG / Mergers - Acquisitions - Takeovers / Sanacorp buys von der Linde Group

--------------------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc. The issuer is responsible
for the content of this announcement.
--------------------------------------------------------------------------------

22.12.2008

The pharmaceutical wholesale company Sanacorp Pharmahandel GmbH
("Sanacorp GmbH"), which is an investment of Sanacorp Pharmaholding
Aktiengesellschaft (ISIN: DE000763131) via its 50 percent interest in
the Italian holding company Millennium S.p.A., has signed an
agreement on the acquisition of von der Linde Group, Düsseldorf in
the afternoon of 22 December 2008. The performance of the agreement,
along with other terms and conditions, is still subject to the
competition authorities´ approval.

Sanacorp GmbH acquires from the family owners all shares in von der
Linde GmbH & Co. Immobilienverwaltung KG, which in turn is sole
shareholder of the operating company v.d. Linde Arzneimittel GmbH.
This company distributes pharmaceutical products to pharmacies from
its branches in Düsseldorf and Herne, generating sales revenue in the
past financial year 2007/2008 of approximately EUR 890 million with a
staff of 848. According to the sales and purchase agreement, Caesar
und Loretz GmbH, which also belongs to Linde Group and produces basic
pharmaceutical substances, is intended to be removed from the
corporate group. Sanacorp GmbH, which generates revenue of
approximately EUR 2.7 billion from 15 branches and anticipates net
income of some EUR 12 million for 2008, will use this transaction to
strengthen its presence in North Rhine-Westphalia. This acquisition
is expected to generate earnings net of refinancing expenses as early
as 2009; subsequently, the expected synergies are supposed to
increase potential dividend payments by up to 25%.

Sanacorp Pharmaholding Aktiengesellschaft
The Management Board

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Sanacorp Pharmaholding AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Florian Meilinger

Telefon: +49(089) 8581 239

E-Mail: f.meilinger@sanacorp.de

Branche: Wholesale
ISIN: DE0007163131
WKN: 716313
Index: CDAX, Classic All Share
Börsen: Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / regulated dealing
Börse Frankfurt / regulated dealing/general standard